We describe the development and evaluation of a hybrid lipopolymeric system comprising carboxymethyl chitosan (CMC), covalently tethered to phosphatidylethanolamine units on the surface of lipid nanovesicles, for oral delivery of paclitaxel. The biopolymer is intended to act as a blanket, thereby shielding the drug from harsh gastrointestinal conditions, whereas the lipid nanovesicle ensures high encapsulation efficiency of paclitaxel and its passive targeting to tumor. CMC-tethered nanovesicles (LN-C-PTX) in the size range of 200-300 nm improved the gastro-intestinal resistance and mucoadhesion properties as compared with unmodified lipid nanovesicles (LN-PTX). Conjugation of CMC did not compromise the cytotoxic potential of paclitaxel yet...
Inhaled chemotherapy for the treatment of lung tumors requires that drug delivery systems improve se...
Cancer continues to pose health problems for people all over the world. Nanoparticles (NPs) have eme...
Combination chemotherapy has been proven promising for cancer treatment, but unsatisfactory therap...
We describe the development and evaluation of a hybrid lipopolymeric system comprising carboxymethyl...
Most biopharmaceutics classification system (BCS) class IV drugs, with poor solubility and inferior ...
Poor delivery of insoluble anticancer drugs has so far precluded their clinical application. In this...
In this work, multifunctional lipid nanocapsules (M-LNC) were designed to combine the activity of th...
Clinical application of paclitaxel (PTX) is limited because of its poor solubility in aqueous media....
Inspired from the apoptotic cascade, we developed phosphatidylserine (PS)-based proapoptotic lipid n...
Abstract Nanocarrier systems are widely used for drug delivery applications, but limitations such as...
In the current study, we developed interpolymer-complex structures composed of hydroxypropyl methylc...
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor activity agains...
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor activity agains...
International audiencePaclitaxel-loaded lipid nanocapsules (PX-LNC) exhibit interesting in vitro cha...
Chemotherapy using cytotoxic agents, such as paclitaxel (PTX), is one of the most effective treatmen...
Inhaled chemotherapy for the treatment of lung tumors requires that drug delivery systems improve se...
Cancer continues to pose health problems for people all over the world. Nanoparticles (NPs) have eme...
Combination chemotherapy has been proven promising for cancer treatment, but unsatisfactory therap...
We describe the development and evaluation of a hybrid lipopolymeric system comprising carboxymethyl...
Most biopharmaceutics classification system (BCS) class IV drugs, with poor solubility and inferior ...
Poor delivery of insoluble anticancer drugs has so far precluded their clinical application. In this...
In this work, multifunctional lipid nanocapsules (M-LNC) were designed to combine the activity of th...
Clinical application of paclitaxel (PTX) is limited because of its poor solubility in aqueous media....
Inspired from the apoptotic cascade, we developed phosphatidylserine (PS)-based proapoptotic lipid n...
Abstract Nanocarrier systems are widely used for drug delivery applications, but limitations such as...
In the current study, we developed interpolymer-complex structures composed of hydroxypropyl methylc...
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor activity agains...
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor activity agains...
International audiencePaclitaxel-loaded lipid nanocapsules (PX-LNC) exhibit interesting in vitro cha...
Chemotherapy using cytotoxic agents, such as paclitaxel (PTX), is one of the most effective treatmen...
Inhaled chemotherapy for the treatment of lung tumors requires that drug delivery systems improve se...
Cancer continues to pose health problems for people all over the world. Nanoparticles (NPs) have eme...
Combination chemotherapy has been proven promising for cancer treatment, but unsatisfactory therap...